Latest Leverage News

FortifAI Limited has acquired FastAI and its cutting-edge Nol8 Technology, driving a 14.7% revenue increase and delivering positive net operating cash flow for the first time in Q2 FY26.

Red Mountain Mining has made significant strides in its critical minerals and gold projects across the US and Australia, highlighted by new claim acquisitions and promising exploration results at key antimony prospects.

NoviqTech has formalised a key collaboration with Viva Energy on sustainable aviation fuel and agreed to acquire biochar carbon removal specialist Coralia, backed by a $1.5 million capital raise.

BOA Resources has secured a significant foothold in Western Australia’s Murchison Copper Belt with a 49% stake in the Neds Creek copper project, setting the stage for targeted drilling and exploration backed by a $3.75 million capital raise.

Cluey Ltd reports a 13% improvement in operating cash outflow and a 0.7% rise in gross profit margin, while preparing to launch its AI-driven Cluey+ platform in February 2026. The company also completed a $4.5 million capital raise and signed an agreement to acquire the Art of Smart group.

Pilot Energy has made significant strides in Q4 2025 with the launch of a modular data centre joint venture, progress on a hybrid solar and battery project, and advancement of offshore gas exploration partnerships, supported by substantial new financing.

Optiscan Imaging Ltd has made significant strides in clinical studies and regulatory readiness, partnering with Australian Clinical Labs and launching new cancer imaging trials as it prepares for multiple FDA submissions in 2026.

Manuka Resources has released an updated 10-year Pre-Feasibility Study for its Cobar Basin projects, revealing a substantial uplift in project economics and a clear path to production by mid-2026.

Nagambie Resources and Alkane Resources have entered a binding agreement for a joint venture that could see Alkane invest up to $27.5 million to earn an 80% stake in Nagambie's key mining tenements, leveraging Alkane’s existing processing infrastructure to accelerate production.

Paradigm Biopharmaceuticals reports solid progress in its Phase 3 knee osteoarthritis trial, expanding internationally and publishing key Phase 2 biomarker data. The company maintains a robust cash position to support ongoing clinical milestones.

Noxopharm has successfully completed dosing in its HERACLES clinical trial for SOF-SKN™, demonstrating strong safety and tolerability. The company also secured a new overseas partnership and its first US patent for the Sofra platform.

Pentanet has reported steady growth in Q2FY26, driven by a strong 5G revenue jump and sustained positive earnings before interest, tax, depreciation, and amortisation (EBITDA). The company’s new brand campaign and subscriber gains signal a strategic push into the second half of the fiscal year.